Page last updated: 2024-10-25

dapi and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

dapi has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies

DAPI: RN given refers to parent cpd.

Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, X1
Wang, X1
Liu, Q1
Wang, P1
Xu, C1
Leung, AW1
Rodley, P1
McDonald, M1
Price, B1
Fright, R1
Morris, C1

Other Studies

2 other studies available for dapi and Leukemia, Myelogenous, Chronic, BCR-ABL Positive

ArticleYear
The role of Beclin 1 in SDT-induced apoptosis and autophagy in human leukemia cells.
    International journal of radiation biology, 2015, Volume: 91, Issue:6

    Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Caspase 3; Fluorescent Dyes; Gene Kno

2015
Comparative genomic hybridization reveals previously undescribed amplifications and deletions in the chronic myeloid leukemia-derived K-562 cell line.
    Genes, chromosomes & cancer, 1997, Volume: 19, Issue:1

    Topics: Female; Fluorescent Dyes; Gene Amplification; Gene Deletion; Humans; Image Processing, Computer-Assi

1997